Bolinger A, Li J, Xie X, Li H, Zhou J
Expert Opin Drug Discov. 2024; 19(9):1023-1041.
PMID: 39078037
PMC: 11390334.
DOI: 10.1080/17460441.2024.2385598.
Luo W, Li K, Dai C, Zhu W, Lin J, Lu F
Infection. 2024; 52(4):1519-1525.
PMID: 38652225
DOI: 10.1007/s15010-024-02255-4.
Stakisaitis D, Kapocius L, Tatarunas V, Gecys D, Mickiene A, Tamosuitis T
Pharmaceutics. 2024; 16(3).
PMID: 38543303
PMC: 10974540.
DOI: 10.3390/pharmaceutics16030409.
Lv B, Gao X, Zeng G, Guo H, Li F
Curr Pharm Des. 2024; 30(9):666-675.
PMID: 38415446
DOI: 10.2174/0113816128280987240214103432.
Shah M, Yamin R, Ahmad I, Wu G, Jahangir Z, Shamim A
PLoS One. 2024; 19(1):e0294769.
PMID: 38175855
PMC: 10766191.
DOI: 10.1371/journal.pone.0294769.
Small-molecule anti-COVID-19 drugs and a focus on China's homegrown mindeudesivir (VV116).
Cao Q, Ding Y, Xu Y, Li M, Zheng R, Cao Z
Front Med. 2024; 17(6):1068-1079.
PMID: 38165534
DOI: 10.1007/s11684-023-1037-3.
An efficient eco-friendly, simple, and green synthesis of some new spiro-N-(4-sulfamoyl-phenyl)-1,3,4-thiadiazole-2-carboxamide derivatives as potential inhibitors of SARS-CoV-2 proteases: drug-likeness, pharmacophore, molecular docking, and DFT....
El-Saghier A, Enaili S, Abdou A, Kadry A
Mol Divers. 2023; 28(1):249-270.
PMID: 37946070
PMC: 10876818.
DOI: 10.1007/s11030-023-10761-0.
Insights into targeting SARS-CoV-2: design, synthesis, studies and antiviral evaluation of new dimethylxanthine derivatives.
Mohamed A, Mostafa A, El Hassab M, Hedeab G, Mahmoud S, George R
RSC Med Chem. 2023; 14(5):899-920.
PMID: 37252103
PMC: 10211320.
DOI: 10.1039/d3md00056g.
Editorial: Host-microbe interaction in SARS-CoV-2 infection: mechanism and intervention.
Kombe Kombe A, Jin T
Front Immunol. 2023; 14:1198868.
PMID: 37143671
PMC: 10152881.
DOI: 10.3389/fimmu.2023.1198868.
Synthesis and in Silico Investigation of Organoselenium-Clubbed Schiff Bases as Potential M Inhibitors for the SARS-CoV-2 Replication.
Shaaban S, Abdou A, Alhamzani A, Abou-Krisha M, Al-Qudah M, Alaasar M
Life (Basel). 2023; 13(4).
PMID: 37109441
PMC: 10141725.
DOI: 10.3390/life13040912.
Identification of novel inhibitors for SARS-CoV-2 as therapeutic options using machine learning-based virtual screening, molecular docking and MD simulation.
Samad A, Ajmal A, Mahmood A, Khurshid B, Li P, Jan S
Front Mol Biosci. 2023; 10:1060076.
PMID: 36959979
PMC: 10028080.
DOI: 10.3389/fmolb.2023.1060076.
Exploring Scoring Function Space: Developing Computational Models for Drug Discovery.
Bitencourt-Ferreira G, Villarreal M, Quiroga R, Biziukova N, Poroikov V, Tarasova O
Curr Med Chem. 2023; 31(17):2361-2377.
PMID: 36944627
DOI: 10.2174/0929867330666230321103731.
Nirmatrelvir exerts distinct antiviral potency against different human coronaviruses.
Li J, Wang Y, Solanki K, Atre R, Lavrijsen M, Pan Q
Antiviral Res. 2023; 211:105555.
PMID: 36791846
PMC: 9925195.
DOI: 10.1016/j.antiviral.2023.105555.
In silico Screening of Potential SARS-CoV-2 Main Protease Inhibitors from .
Mengist H, Khalid Z, Adane F
Adv Appl Bioinform Chem. 2023; 16:1-13.
PMID: 36699952
PMC: 9868284.
DOI: 10.2147/AABC.S393084.
Small molecules in the treatment of COVID-19.
Lei S, Chen X, Wu J, Duan X, Men K
Signal Transduct Target Ther. 2022; 7(1):387.
PMID: 36464706
PMC: 9719906.
DOI: 10.1038/s41392-022-01249-8.
Repurposing of HIV/HCV protease inhibitors against SARS-CoV-2 3CL.
Ma L, Li Q, Xie Y, Zhao J, Yi D, Guo S
Antiviral Res. 2022; 207:105419.
PMID: 36155070
PMC: 9499987.
DOI: 10.1016/j.antiviral.2022.105419.
Bioactive natural products in COVID-19 therapy.
Wang Z, Wang N, Yang L, Song X
Front Pharmacol. 2022; 13:926507.
PMID: 36059994
PMC: 9438897.
DOI: 10.3389/fphar.2022.926507.
Chemistry of Protein-Phenolic Interactions Toward the Microbiota and Microbial Infections.
Yilmaz H, Subasi B, Celebioglu H, Ozdal T, Capanoglu E
Front Nutr. 2022; 9:914118.
PMID: 35845785
PMC: 9284217.
DOI: 10.3389/fnut.2022.914118.
The SARS-CoV-2 main protease (M): Structure, function, and emerging therapies for COVID-19.
Hu Q, Xiong Y, Zhu G, Zhang Y, Zhang Y, Huang P
MedComm (2020). 2022; 3(3):e151.
PMID: 35845352
PMC: 9283855.
DOI: 10.1002/mco2.151.
SARS-CoV-2 Infection, Sex-Related Differences, and a Possible Personalized Treatment Approach with Valproic Acid: A Review.
Stakisaitis D, Kapocius L, Valanciute A, Balnyte I, Tamosuitis T, Vaitkevicius A
Biomedicines. 2022; 10(5).
PMID: 35625699
PMC: 9138665.
DOI: 10.3390/biomedicines10050962.
